Talk:OncoMed

Latest comment: 9 years ago by 98.155.30.229

The article refers to Verastem as a "direct competitor" of Oncomed. Is this truly the case? It is common practice to improve efficacy by giving multiple drugs in combination, especially if neither has significant side effects. (IE are Oncomed and Verastem complementary, like a doctor and a nurse, or truly adversarial?) Note that Oncomed founder Max Wicha is on the scientific advisory board of Verastem. 98.155.30.229 (talk) 02:58, 30 May 2015 (UTC)Reply